Skip to content
Home/Companies/Biotech/aquila biolabs

aquila biolabs

Biotech·Germany·Exited 2021·Held 6yr
Entry
2015
Hold
6yr
Exit
2021

Who owns aquila biolabs?

aquila biolabs was owned by S-UBG AG Aachen Krefeld Mönchengladbach through Seed Fonds Aachen (2008 vintage) from 2015 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-10

S-UBG AG Aachen Krefeld Mönchengladbach
Investor
S-UBG AG Aachen Krefeld Mönchengladbach
Seed Fonds Aachen · 2008 · VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from Seed Fonds Aachen

Other portfolio companies in the same fund.

MOQO
MOQO
Active
MobilityGermany· 2019
Taxy.io
Taxy.io
Exited 2025
FintechGermany· 2019
to
Protembis
Protembis
Active
MedTechGermany· 2018
Silexica
Exited 2021
DevToolsGermany· 2015
to
m2p-labs
Exited 2020
BiotechGermany· 2008
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track aquila biolabs

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on aquila biolabs.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue